| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |